Indefinite Delivery Contract 36E79725D0036
Award Date
9/7/25
Last Date to Order
9/6/26
Federal Agency
National Acquisition Center
Awardee
Exelan Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs National Acquisition Center awarded an indefinite delivery contract to The Harvard Drug Group, L.L.C. DBA Major Pharmaceuticals and Rugby Laboratories to supply tamsulosin hydrochloride capsules. The single award contract has a potential value of $62.9 million and a period of performance of June 1, 2022 through May 31, 2023 with four one-year option periods. Delivery will be made to the VA, DoD, Bureau of Prisons, and Indian Health Service through the...
This Indefinite Delivery Contract (IDC) was awarded by the VA National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract has a ceiling value of $10,379,933.80 and a period of performance from October 27, 2022 to October 26, 2025, with four one-year option periods. The contract is for the delivery of Sildenafil Citrate tablets in various strengths and package sizes to support the medication needs of the...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The single-award, unrestricted contract has a ceiling value of $28,781,200.00 and a period of performance from February 19, 2023 to February 18, 2026, with four one-year option periods. The contract is for the delivery of six line items of Prazosin HCL capsules in...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The single-award, unrestricted IDC has a ceiling value of $4,792,297.44 and a period of performance through December 19, 2025. The contract covers the delivery of a variety of generic pharmaceutical products, including Dofetilide Capsules, to the VA, Department of...
This indefinite delivery contract was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract has a ceiling value of $10,164,262.95 and a period of performance from February 22, 2024 to February 21, 2026. The purpose of this contract is to procure oseltamivir phosphate capsules and suspension for distribution to the VA, Department of Defense...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award, unrestricted Indefinite Delivery Contract (IDC) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract, valued at a ceiling of $48,442,917.75, is for the supply of Escitalopram Oxalate Tablets in various package sizes to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract has a...
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The single-award contract, valued at a ceiling of $12,802,166.10, is for the delivery of Ramipril capsules in various strengths and package sizes. The period of performance is from March 14, 2022, to March 13, 2023, with four one-year option periods. The...
This Indefinite Delivery Contract (IDC) with a ceiling value of $5,592,523.40 was awarded by the Defense Logistics Agency (DLA) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract, which has a period of performance through June 7, 2026, is for the manufacture and distribution of various pharmaceutical products, including generic medications such as ibuprofen, citalopram, oseltamivir phosphate, and alfuzosin HCl. Exelan...
This single-award Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company. The IDC has a ceiling value of $7,656,786.70 and a period of performance from June 3, 2025 to June 2, 2026, with four one-year option periods. The contract primarily consists of 6 line items for the delivery of Cyclobenzaprine HCL Tablets in various package sizes, including 30,...
The federal contract IDV award SPE2D219D0070 was granted to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The IDV is a single-award indefinite delivery contract with a ceiling value of $45,158,494.05 and an ultimate completion date of May 28, 2024. Exelan Pharmaceuticals, a key supplier of generic and branded pharmaceutical products to various federal healthcare agencies, will deliver a diverse range of pharmaceutical items...